217 related articles for article (PubMed ID: 6427483)
1. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.
Huland H; Otto U; Droese M; Klöppel G
J Urol; 1984 Jul; 132(1):27-9. PubMed ID: 6427483
[TBL] [Abstract][Full Text] [Related]
2. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
Zincke H; Benson RC; Hilton JF; Taylor WF
J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
[TBL] [Abstract][Full Text] [Related]
3. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
4. Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer.
Flamm J
Eur Urol; 1990; 17(2):119-24. PubMed ID: 2178939
[TBL] [Abstract][Full Text] [Related]
5. [Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression].
Iborra Juan I; Ricos Torrent JV; Monrós Lliso JL; Dumont Martínez R; Casanova Ramón-Borja J; Solsona Narbón E
Arch Esp Urol; 1992 Dec; 45(10):1001-7. PubMed ID: 1294028
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
Schwaibold H; Pichlmeier U; Klingenberger HJ; Huland H
Eur Urol; 1997; 31(2):153-9. PubMed ID: 9076457
[TBL] [Abstract][Full Text] [Related]
7. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
8. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
Giesbers AA; Van Helsdingen PJ; Kramer AE
Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment for superficial bladder cancer following transurethral resection.
Hirao Y; Okajima E; Ohara S; Ozono S; Hiramatsu T; Yoshida K; Yamada K; Aoyama H; Hashimoto M; Watanabe S
Cancer Chemother Pharmacol; 1987; 20 Suppl():S85-90. PubMed ID: 3117402
[TBL] [Abstract][Full Text] [Related]
11. Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.
Maier U; Baumgartner G
J Urol; 1989 Mar; 141(3):529-30. PubMed ID: 2493098
[TBL] [Abstract][Full Text] [Related]
12. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
13. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
Wajsman Z; Dhafir RA; Pfeffer M; MacDonald S; Block A; Dragone N; Pontes JE
J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
[TBL] [Abstract][Full Text] [Related]
14. A randomized multicenter trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus bacillus Calmette-Guerin. Participating Clinics.
Krege S; Giani G; Meyer R; Otto T; Rübben H
J Urol; 1996 Sep; 156(3):962-6. PubMed ID: 8709374
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
Flüchter SH; Bichler KH; Harzmann R; Erdmann D
Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.
Tolley DA; Parmar MK; Grigor KM; Lallemand G; Benyon LL; Fellows J; Freedman LS; Grigor KM; Hall RR; Hargreave TB; Munson K; Newling DW; Richards B; Robinson MR; Rose MB; Smith PH; Williams JL; Whelan P
J Urol; 1996 Apr; 155(4):1233-8. PubMed ID: 8632538
[TBL] [Abstract][Full Text] [Related]
17. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
[TBL] [Abstract][Full Text] [Related]
18. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
19. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
Maier U; Höbarth K
Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy for superficial bladder cancer.
Baselli EC; Greenberg RE
Oncology (Williston Park); 2001 Jan; 15(1):85-8; discussion 88-91. PubMed ID: 11271984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
